Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.3 was added to the history and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) added and an older revision (v3.2.0) removed, which are minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe notice about government funding lapse and operating status was removed from the page header. Previously, the notice informed users about potential delays and directed them to update sources.SummaryDifference0.7%

- Check57 days agoChange DetectedThe new screenshot adds multiple history versions (3–11) with updated study status entries and dates, expanding the change log for NCT05557838. This provides a fuller view of how the trial record has evolved over time.SummaryDifference0.1%

- Check85 days agoChange DetectedMajor update: adds a government-funded operation status notice and version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference12%

- Check92 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.